Vyome Holdings, Inc (HIND) stock
HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.54+0.01 (+0.98%)
Close on Nov 17, 2026Market cap $10.84MP/E –Yield –
Vyome price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Vyome's price to sales ratio was 84.9× on Nov 11, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.0× to 116.9×, with a median of 0.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 84.9× | +84.7 |
| 2025 | Oct 31, 2025 | 0.2× | −0.1 |
| 2024 | Dec 31, 2024 | 0.3× | +0.2 |
| 2023 | Dec 29, 2023 | 0.0× | −0.1 |
| 2022 | Dec 30, 2022 | 0.1× | −0.9 |
| 2021 | Dec 31, 2021 | 1.0× | −1.4 |
| 2020 | Dec 31, 2020 | 2.5× | −2.3 |
| 2019 | Dec 31, 2019 | 4.7× | −2.0 |
| 2018 | Dec 31, 2018 | 6.7× | −18.0 |
| 2017 | Dec 29, 2017 | 24.7× | – |
See a number that looks wrong?